Company Overview and News

55
Rogers Communications (RCI) Q1 Earnings: What's in Store?

2018-04-17 zacks
Rogers Communications Inc. (RCI - Free Report) is set to release first-quarter 2018 results on Apr 19. The company beat the Zacks Consensus Estimate in the trailing four quarters, with an average positive surprise of 4.97%. In fourth-quarter 2017, earnings of 69 cents per share outpaced the Zacks Consensus Estimate by a penny. Although revenues of $2.86 billion lagged the consensus mark, the figure increased 3% year over year driven by solid result from the Wireless segment.
RCI SJR.B APO.PRB APO.PRA WDC MS.PRE SJR MS.PRF SJRWF MS.PRG MS.PRA APO PAYC SJR.A BCE RCIAF MS.PRI MS.PRK SJR.PR.A MS

11
Can TransDigm Maintain Impressive Momentum Amid Risks?

2018-04-16 zacks
TransDigm Group Inc. (TDG - Free Report) has managed to impress investors with its recent earnings streak, wherein the company’s bottom line has trumped estimates thrice in the trailing four quarters. TransDigm’s impressive business model actively works toward strengthening and enhancing its position in highly-engineered proprietary aerospace components’ niche markets.
SJR.B TDG RTN CW SJR SJRWF SJR.PR.A COL SJR.A

5
Here's Why You Should Buy Universal Forest (UFPI) Stock Now

2018-04-16 zacks
We believe that Universal Forest Products, Inc. (UFPI - Free Report) is a solid choice for investors, seeking exposure in the building products space. Strengthening product portfolio, rising demand for repair and remodeling activities, healthy housing starts and synergistic benefits from acquired assets will be advantageous for the company. The stock, with approximately $2 billion market capitalization, has been upgraded to a Zacks Rank #1 (Strong Buy) on Apr 14.
LPX UFPI LPCCW SJR.B SJR SJRWF SJR.PR.A SJR.A

177
Shaw Communications (SJR) Beats on Q2 Earnings & Revenues

2018-04-16 zacks
Shaw Communications Inc. (SJR - Free Report) delivered second-quarter fiscal 2018 adjusted earnings from continuing operations of 40 cents per share beating the Zacks Consensus Estimate by 17 cents. The figure surged almost 68% from the year-ago quarter. Including restructuring charges of C$417 million, the company reported loss of 33 cents per share. The company incurred the charges related to Total Business Transformation (“TBT”) initiative and Voluntary Departure Program (“VDP”) restructuring programs.
CABO RHI SJR.B KMI.WS SJR SJRWF SJR.A KMI.PRA KMI AAPL SJR.PR.A KMR CVB KMRFZ

27
Archrock (AROC) Shares March Higher, Can It Continue?

2018-04-16 zacks
As of late, it has definitely been a great time to be an investor in Archrock, Inc. (AROC - Free Report) . The stock has moved higher by 7.6% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance and favorable technical, could suggest that the stock may be on the right path.
CORI SJR.B SJR AROC SJRWF MBUU SJR.PR.A SJR.A

20
Can The Uptrend Continue for Synchronoss Technologies (SNCR)?

2018-04-16 zacks
Investors certainly have to be happy with Synchronoss Technologies, Inc. (SNCR - Free Report) and its short term performance. After all, the stock has jumped by 12.2% in the past 4 weeks, and it is also above its 20 Day Simple Moving Average as well. This is certainly a good trend, but investors are probably asking themselves, can this positive trend continue for SNCR?
CORI SNCR SJR.B SJR SJRWF MBUU SJR.PR.A SJR.A

20
Will Natural Resource Partners (NRP) Continue to Surge Higher?

2018-04-16 zacks
As of late, it has definitely been a great time to be an investor in Natural Resource Partners L.P. (NRP - Free Report) . The stock has moved higher by 17.9% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance and favorable technical, could suggest that the stock may be on the right path.
CORI SJR.B NRP SJR SJRWF MBUU SJR.PR.A SJR.A

19
Can the Rally in Bancolombia (CIB) Shares Continue?

2018-04-16 zacks
Bancolombia S.A. (CIB - Free Report) has been on the move lately as the stock has risen by 15.7% in the past four weeks, and it is currently trading well above its 20-Day SMA. This is a pretty solid move higher, but the question that has to be on investors’ minds right now is; can this trend continue?
CORI SJR.B SJR SJRWF MBUU SJR.PR.A SJR.A

19
Why Copart, Inc. (CPRT) is Poised to Beat Earnings Estimates Again

2018-04-13 zacks
Looking for a stock that might be in a good position to beat earnings at its next report? Consider Copart, Inc. (CPRT - Free Report) , a firm in the Auction and Valuation Services industry, which could be a great candidate for another beat. This company has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. In fact, in these reports, CPRT has beaten estimates by at least 20% in both cases, suggesting it has a nice short-term history of crushing expectations.
CORI GD SIG SJR.B CPRT SJR SJRWF SJR.PR.A SJR.A SIG

23
Shaw Communications profit beats on strong wireless growth

2018-04-12 channelnewsasia
REUTERS: Shaw Communications Inc's quarterly profit easily topped analysts' estimates on Thursday as the Canadian telecom services company's investments in its wireless business helped more than double subscriber additions.
BCE RCIAF RCI SJR.B SJR SJRWF SJR.PR.A TU SJR.A

4
Shaw shares jump on strong Q2 results

2018-04-12 cbc.ca
Shaw Communications Inc. shares gained almost 10 per cent Thursday as strong operational performance by its main business units offset concerns about $417 million in restructuring-related costs booked in its second quarter.
SJR.B SJR SJRWF SJR.PR.A SJR.A

4
Shaw Communications shares up, offsetting concerns over massive restructuring

2018-04-12 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
SJR.B SJR SJRWF SJR.PR.A SJR.A

4
UPDATE 2-Canada's Corus beats profit estimates, shares rise

2018-04-05 reuters
(Reuters) - Canadian media company Corus Entertainment Inc (CJRb.TO) beat quarterly profit estimates and aims to focus on targeted advertisements to increase revenue from TV this year, sending its shares up as much as 25 percent Thursday morning.
CJREF SJR.B CJR.B SJR SJRWF SJR.PR.A SJR.A

4
Quebecor ready to invest in wireless, cable operations, CEO says

2018-03-14 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
RCIAF RCI SJR.B SJR SJRWF SJR.PR.A QBCRF SJR.A QBCAF

6
Shaw: Too Much In Too Little Time

2018-03-12 seekingalpha
The company is looking to grow its wireless division by focusing on 5G, but development of 5G is expensive and Shaw has other financial commitments.
RCI SJR.B SJR SJRWF SJR.PR.A TU SJR.A

Related Articles

CASC: Cascadian Therapeutics Analysis and Research Report

7h - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

8h - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

CUSIP: 82028K101